Novartis Drug Exjade(R) Recommended by CHMP for EU Approval to Treat

Novartis drug Exjade(R) recommended by CHMP for EU approval to treat

Filed under: drug treatment news 2010

Novartis International AG / Novartis drug Exjade® recommended by CHMP for EU approval to treat patients with non-transfusion-dependent thalassemia syndromes . Processed and transmitted by Thomson Reuters ONE. …. Position Paper 5.2. March 20, 2012 …
Read more on Reuters

 

Five Bio-pharmas That Look Ready For Upside Gains

Filed under: drug treatment news 2010

On August 27, 2012, the company announced that its drug eteplirsen, developed for the treatment of Duchenne muscular dystrophy, received positive early clinical trial results. Jerry Mendell, M.D., Director of the Centers for …. In July 2010 …
Read more on Proactive Investors USA & Canada

 

Man headed to prison for drug convictions

Filed under: drug treatment news 2010

Knight last year tried to make an example of Demetrius E. Washington because of Washington's refusal to cooperate in the investigation of Aaron Hobson's murder in a Break Time parking lot in October 2010. Washington pleaded guilty to first-degree drug …
Read more on Columbia Daily Tribune